Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Mol Cell Endocrinol. 2013 Apr 6;372(0):57–64. doi: 10.1016/j.mce.2013.03.021

Figure 1. GDF-9 and activin dose-dependently increase follistatin mRNA expression in primary rat GCs.

Figure 1

GCs were treated with increasing doses of GDF-9 or activin A for 15 hr before evaluation of follistatin mRNA expression. Follistatin mRNA levels were measured by quantitative real-time PCR and normalized to L19 mRNA levels. Results were evaluated by a one-way ANOVA followed by Tukey’s posthoc analysis. Different letters indicate a significant difference (p < 0.05) between groups within each treatment. Values shown are mean ± SEM. N = 3.